These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24522918)

  • 41. Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.
    Lai KY; Chou YC; Lin JH; Liu Y; Lin KM; Doong SL; Chen MR; Yeh TH; Lin SJ; Tsai CH
    J Virol; 2015 Jun; 89(11):5968-80. PubMed ID: 25810549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. hTERT inhibits the Epstein-Barr virus lytic cycle and promotes the proliferation of primary B lymphocytes: implications for EBV-driven lymphomagenesis.
    Terrin L; Dolcetti R; Corradini I; Indraccolo S; Dal Col J; Bertorelle R; Bonaldi L; Esposito G; De Rossi A
    Int J Cancer; 2007 Aug; 121(3):576-87. PubMed ID: 17417773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. B Cell Receptor-Responsive miR-141 Enhances Epstein-Barr Virus Lytic Cycle via FOXO3 Inhibition.
    Chen Y; Fachko DN; Ivanov NS; Skalsky RL
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33853871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
    Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
    J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
    J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
    Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
    J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression.
    Jones RJ; Iempridee T; Wang X; Lee HC; Mertz JE; Kenney SC; Lin HC; Baladandayuthapani V; Dawson CW; Shah JJ; Weber DM; Orlowski RZ
    Clin Cancer Res; 2016 Oct; 22(19):4901-4912. PubMed ID: 27297582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viral reprogramming of the Daxx histone H3.3 chaperone during early Epstein-Barr virus infection.
    Tsai K; Chan L; Gibeault R; Conn K; Dheekollu J; Domsic J; Marmorstein R; Schang LM; Lieberman PM
    J Virol; 2014 Dec; 88(24):14350-63. PubMed ID: 25275136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IFI16 Partners with KAP1 to Maintain Epstein-Barr Virus Latency.
    Xu H; Li X; Rousseau BA; Akinyemi IA; Frey TR; Zhou K; Droske LE; Mitchell JA; McIntosh MT; Bhaduri-McIntosh S
    J Virol; 2022 Sep; 96(17):e0102822. PubMed ID: 35969079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CpG-methylation regulates a class of Epstein-Barr virus promoters.
    Bergbauer M; Kalla M; Schmeinck A; Göbel C; Rothbauer U; Eck S; Benet-Pagès A; Strom TM; Hammerschmidt W
    PLoS Pathog; 2010 Sep; 6(9):e1001114. PubMed ID: 20886097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.
    Paschos K; Smith P; Anderton E; Middeldorp JM; White RE; Allday MJ
    PLoS Pathog; 2009 Jun; 5(6):e1000492. PubMed ID: 19557159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
    Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
    Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.
    Countryman JK; Gradoville L; Miller G
    J Virol; 2008 May; 82(10):4706-19. PubMed ID: 18337569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus.
    Giunco S; Celeghin A; Gianesin K; Dolcetti R; Indraccolo S; De Rossi A
    Cell Death Dis; 2015 May; 6(5):e1774. PubMed ID: 26018735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator.
    Francis A; Ragoczy T; Gradoville L; Heston L; El-Guindy A; Endo Y; Miller G
    J Virol; 1999 Jun; 73(6):4543-51. PubMed ID: 10233912
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of Rta in B Lymphocytes during Epstein-Barr Virus Latency.
    Hwang SP; Huang LC; Wang WH; Lin MH; Kuo CW; Huang HH; Chang LK
    J Mol Biol; 2020 Sep; 432(19):5227-5243. PubMed ID: 32710985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.
    Li L; Su X; Choi GC; Cao Y; Ambinder RF; Tao Q
    BMC Cancer; 2012 Mar; 12():125. PubMed ID: 22458933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.
    Wille CK; Nawandar DM; Henning AN; Ma S; Oetting KM; Lee D; Lambert P; Johannsen EC; Kenney SC
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7257-65. PubMed ID: 26663912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication.
    Li Y; Long X; Huang L; Yang M; Yuan Y; Wang Y; Delecluse HJ; Kuang E
    J Virol; 2016 Jan; 90(2):887-903. PubMed ID: 26537683
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.
    Prince S; Keating S; Fielding C; Brennan P; Floettmann E; Rowe M
    J Virol; 2003 Apr; 77(8):5000-7. PubMed ID: 12663807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.